Error: Could not add to watchlist. X

InMed Pharmaceuticals Inc

+ Watchlist
MWG2:GR
Frankfurt
0.11
EUR
0.01
5.04%
As of 03:35:11 ET on 07/07/2015.
Open
0.11
Day Range
0.11 - 0.11
Volume
0
Previous Close
0.12
52Wk Range
0.06 - 0.41
1 Yr Return
-71.89%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (m EUR)
6.532
Shares Outstanding (m)
57.810
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
InMed Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops cannabis-based botanical and non-botanical therapies through research and development into the extensive pharmacology of cannabinoids. InMed Pharmaceuticals focuses on its proprietary platform technology, drug discovery, and commercialization development.
ADDRESS
350-409 Granville Street
Vancouver, BC V6C 1T2
Canada
PHONE
604-669-7207
  • Craig D Schneider
    President/CEO
  • Terese J Gieselman
    CFO/Secretary
  • Ado Mohammed
    Chief Medical Officer
  • Sazzad Hossain
    Chief Scientific Officer/Co-Founder
Show More